Stock TLX TELIX PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Calendar Telix Pharmaceuticals Limited

Equities

TLX

AU000000TLX2

Biotechnology & Medical Research

Delayed Australian S.E.
Other stock markets
 10:53:06 2024-12-09 pm EST 		5-day change 1st Jan Change
24.53 AUD -1.09% Intraday chart for Telix Pharmaceuticals Limited -0.79% +143.30%
Nov. 28 Telix Pharmaceuticals Limited and Grand Pharmaceutical Group Limited Announces First Patient Dosed in Phase III ZIRCON-CP Trial of TLX250-CDx for Kidney Cancer Imaging in Chinese Patients CI
Nov. 19 Telix Pharmaceuticals Secures License to Cancer Treatments in Germany MT

Chart calendar Telix Pharmaceuticals Limited

f55a8e3eb7660ee.DlCkHT5vevUaoIe52ULgoZMT1w4hAsr-f6OIYUxapm4.SA_cXApZEr5K5_Xzqje1x-IkoFdKaJ-hOcrADjUL5A9vPPF-dC0JkVjYwg~ac1981f10f90f65a1f1854e3e7271d0c

Upcoming events on Telix Pharmaceuticals Limited

2025-02-18 Q4 2024 Earnings Release (Projected)
2025-08-20 Q2 2025 Earnings Release (Projected)
2026-02-24 Q4 2025 Earnings Release (Projected)
2026-08-19 Q2 2026 Earnings Release (Projected)

Past events on Telix Pharmaceuticals Limited

2024-10-17 02:08 am September 2024 Sales and Revenue Release - Activities Report
2024-08-22 07:00 pm Q2 2024 Earnings Call
2024-08-22 02:41 am Q2 2024 Earnings Release
2024-07-30 07:30 pm TLX250-CDx Update Call
2024-07-17 06:32 pm June 2024 Sales and Revenue Release - Activities Report
2024-05-21 Annual General Meeting
2024-04-17 02:07 am March 2024 Sales and Revenue Release - Activities Report
2024-04-04 07:00 pm Shareholders Meeting
2024-03-04 ASX CEO Connect Meeting
2024-02-22 05:00 pm Q4 2023 Earnings Call
2024-02-22 04:22 am Q4 2023 Earnings Release
2024-01-09 06:00 pm JPMorgan Healthcare Conference
2023-12-05 San Antonio Breast Cancer Symposium
2023-11-20 06:15 pm Investor Meeting - Key Opinion Leader
2023-11-15 11:00 am Jefferies London Healthcare Conference
2023-10-18 05:30 pm September 2023 Sales and Revenue Call - Activities Report
2023-10-18 03:37 am September 2023 Sales and Revenue Release - Activities Report
2023-08-23 06:30 pm Q2 2023 Earnings Call
2023-08-23 04:44 am Q2 2023 Earnings Release
2023-07-19 06:30 pm June 2023 Sales and Revenue Call - Activities Report

Annual results

Fiscal PeriodDecember 2021 2022 2023 2024 2025 2026
Net sales
Million AUD		Released
Forecast
Spread 		7,60
8,19
-7.29%		160
156
2.39%		503
501
0.34%
770


1 011


1 348

EBITDA
Million AUD		Released
Forecast
Spread 		-70,1
-48,5
-44.42%		-67,8
-69,5
2.43%		58,4
63,8
-8.48%
116


155


291

EBIT
Million AUD		Released
Forecast
Spread 		-75,2
-56,5
-33.09%		-73,2
-75,0
2.43%		51,7
46,1
12.25%
107


157


272

Earnings before Tax (EBT)
Million AUD		Released
Forecast
Spread 		-80,5
-50,5
-59.34%		-98,6
-74,7
-31.95%		3,09
28,9
-89.31%
84,9


146


259

Net income
Million AUD		Released
Forecast
Spread 		-80,5
-50,9
-58.1%		-104
-79,7
-30.63%		5,21
8,78
-40.65%
57,1


82,1


180

EPS
AUD		Released
Forecast
Spread 		-0,29
-0,18
-56.34%		-0,34
-0,25
-36.73%		0,02
0,04
-59.17%
0,16


0,24


0,52

Announcement Date23/02/2227/02/2322/02/24-

Quarterly results

Fiscal PeriodJune 2022 Q4 2022 S2 2023 Q2 2023 S1 2023 S2 2024 S1 2024 Q4 2024 S2 2025 Q2 2025 S1 2025 Q4 2025 S2
Net sales
Million AUD		Released
Forecast
Spread 		80,7
68,9
17.28%		136
128
6.26%		121


221
220
0.56%		282
278
1.3%		364
364
-0.01%
391


398


420


432


486


508

EBITDA
Million AUD		Released
Forecast
Spread


-7,05
-13,6
48.19%


34,7
33,9
2.58%		23,7
48,6
-51.16%






66,2













EBIT
Million AUD		Released
Forecast
Spread


-9,70
-10,1
3.92%


31,5
27,7
14.03%		20,2
53,5
-62.31%		26,0
58,9
-55.85%

















Earnings before Tax (EBT)
Million AUD		Released
Forecast
Spread














34,7
58,9
-41.12%



30,3





47,4





108

Net income
Million AUD		Released
Forecast
Spread


-33,2
-25,2
-31.7%





19,5
16,7
16.95%		29,7
46,6
-36.3%



35,7





30,9





91,1

EPS
AUD		Released
Forecast
Spread














0,09
0,15
-41.67%



0,06





0,10





0,25

Announcement Date27/02/2327/02/2323/08/2323/08/2322/02/2422/08/24------

Upcoming sector events for Telix Pharmaceuticals Limited

2025-01-22 SYNGENE INTERNATIONAL LIMITED: Q3 2025 Earnings Release
2025-01-24 LONZA GROUP AG: Q4 2024 Earnings Release
2025-02-03 BIO-TECHNE CORPORATION: Q2 2025 Earnings Release (Projected)
2025-02-05 REPLIMUNE GROUP, INC.: Q3 2025 Earnings Release (Projected)
2025-02-05 TAKARA BIO INC.: Q3 2024 Earnings Release (Projected)
2025-02-10 AZENTA, INC.: Q1 2025 Earnings Release (Projected)
2025-02-10 QIAGEN N.V.: Q4 2024 Earnings Release (Projected)
2025-02-11 IMMUNOVANT, INC.: Q3 2025 Earnings Release (Projected)
2025-02-11 GNI GROUP LTD.: Q4 2024 Earnings Release (Projected)
2025-02-11 CHARLES RIVER LABORATORIES INTERNATIONAL, INC.: Q4 2024 Earnings Release (Projected)
More events

Past sector events for Telix Pharmaceuticals Limited

2024-11-27 FORMYCON AG: Q3 2024 Earnings Release
2024-11-20 07:00 am SEPTERNA, INC.: Q3 2024 Earnings Release
2024-11-20 02:00 am GENUS PLC: Q1 2025 Sales and Revenue Release - Trading Update
2024-11-19 MESOBLAST LIMITED: Q1 2025 Earnings Release (Projected)
2024-11-14 08:00 am ARRIVENT BIOPHARMA, INC.: Q3 2024 Earnings Release
2024-11-14 08:00 am SILENCE THERAPEUTICS PLC: Q3 2024 Earnings Release
2024-11-14 02:00 am BIOARCTIC AB: Q3 2024 Earnings Release
2024-11-13 VORONOI, INC.: Q3 2024 Earnings Release
2024-11-13 GNI GROUP LTD.: Q3 2024 Earnings Release
2024-11-13 04:10 pm PHARVARIS N.V.: Q3 2024 Earnings Release

Quarterly revenue - Rate of surprise

quality-estimates-chart TELIX-PHARMACEUTICALS-LIM

Net sales - Rate of surprise

quality-estimates-chart TELIX-PHARMACEUTICALS-LIM

Annual profits - Rate of surprise

quality-estimates-chart TELIX-PHARMACEUTICALS-LIM
  1. Stock Market
  2. Equities
  3. TLX Stock
  4. Calendar Telix Pharmaceuticals Limited